BIOVITA
DEAD

Serial Number

98299440

Owner

Ildong Pharmaceutical Co., Ltd.

Attorney

Michael B. Chesal

First Use Date

Aug 1, 2022

Filing Date

Dec 5, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BIOVITA Trademark

Serial Number: 98299440

BIOVITA is a trademark filed by Ildong Pharmaceutical Co., Ltd. on December 5, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Ildong Pharmaceutical Co., Ltd.

2, Baumoe-ro 27-gil, Seocho-gu
Seoul 06752 , KR

Entity Type: 16

Trademark Details

Filing Date

December 5, 2023

Registration Date

Not Registered

First Use Anywhere

August 1, 2022

First Use in Commerce

October 1, 2023

Goods & Services

Dietary and nutritional supplements

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 7, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 7, 2026 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 6, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 6, 2025 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 23, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 22, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 22, 2025 GNSL
SUSPENSION LETTER WRITTEN
Feb 22, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 23, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 25, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 25, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 25, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 25, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 25, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 29, 2024 NWOS
NEW APPLICATION ENTERED
Dec 5, 2023 NWAP